Remnant cholesterol, lipid ratios, and the severity of coronary artery lesions: a retrospective cohort study in patients with coronary heart disease
Open accessThe DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index; 15 of the 18 sources its claims cite were checked for support.
Abstract
Background Emerging genetic and observational evidence indicates that remnant cholesterol (RC) is a significant residual risk factor for cardiovascular diseases. However, there is a relative paucity of evidence exploring the correlation among RC, lipid ratios, and atherosclerotic lesion severity. This study aimed to investigate the predictive value of RC and lipid ratios alone or in combination for the severity of coronary artery stenosis in patients with coronary heart disease (CHD). Methods The Gensini score was used to assess the severity of coronary atherosclerotic lesions. CHD patients were categorized into mild stenosis and moderate-to-severe stenosis groups. Logistic regression was used to evaluate the risk of a high Gensini score associated with RC and lipid ratios. Our study also examined the relationship between inconsistencies in RC and non-high-density lipoprotein cholesterol (non-HDL-C) levels and the severity of coronary artery stenosis. Receiver operating characteristic (ROC) curves were used to assess the predictive power of RC and lipid ratios alone or in combination for moderate to severe coronary artery lesions. Results Multivariate regression models suggested that RC was a strong predictor of moderate to severe coronary artery stenosis [odds ratio (OR): 5.44, P < 0.001]. When grouped by curve-fitting inflection points, the group with inconsistent high RC/low non-HDL-C, rather than the low RC/high non-HDL-C group, was associated with an increased risk of moderate to severe coronary stenosis compared with the consistent low RC group (OR: 2.72, P < 0.001). ROC curves showed that RC predicted an area under the curve (AUC) of 0.715 for coronary stenosis severity, improving the predictive efficacy of the combined predictors comprising lipid ratios (AUC: 0.723 vs. 0.703, P < 0.05). Conclusions RC and various lipid ratios [triglyceride/HDL-C, total cholesterol/HDL-C, low-density lipoprotein cholesterol/HDL-C, and apoloprotein (apo)B/apoA] correlated with the degree of coronary artery stenosis in patients with CHD, suggesting that RC has potential value as a biomarker reflecting the degree of coronary artery stenosis independent of the traditional risk factors and the levels of non-HDL-C. This could enhance the predictive efficacy based on the lipid ratio model and had better predictive value for moderate to severe coronary artery lesions.
Overview
CoChat Summary
## TL;DR
In 452 patients with coronary heart disease, higher remnant cholesterol (RC) and several lipid ratios were associated with more severe coronary artery stenosis by Gensini score. RC was the strongest single predictor reported, and adding RC improved the predictive performance of a lipid-ratio model.
## Key findings
- The study included 452 CHD patients after excluding 102 who did not meet criteria and 46 with incomplete baseline data; 217 had mild stenosis and 235 had moderate-to-severe stenosis.
- In multivariable logistic regression, RC was an independent risk factor for moderate-to-severe coronary stenosis with OR 5.44 (95% CI 2.65–11.15, P < 0.001); ApoB/ApoA also showed a strong association (OR 5.00, 95% CI 2.17–11.51, P < 0.001).
- By quartiles, the Q4 RC group had 7.37 times the risk of the Q1 group in Model 3 (P < 0.001).
- ROC analysis found RC AUC = 0.715 (sensitivity 77.4%, specificity 60.8%); the combined predictor improved to AUC 0.723 versus 0.703 for the lipid-ratio model alone (P < 0.05).
- For RC/non-HDL-C inconsistency, the consistent high RC group had OR 4.32 (95% CI 2.15–8.66, P < 0.001) and the high RC/low non-HDL-C group had OR 2.72 (95% CI 1.64–4.52, P < 0.001) versus the consistent low RC group.
## Methods
- Design/sample: Single-center retrospective cohort of 600 CHD patients undergoing coronary angiography at the Second Affiliated Hospital of Baotou Medical College between January 2022 and December 2023; 452 met inclusion criteria.
- Outcome/exposures: Coronary lesion severity assessed with the Gensini score and dichotomized into mild (<36) vs moderate-to-severe (≥36) stenosis; exposures included RC, non-HDL-C, and lipid ratios (TG/HDL-C, TC/HDL-C, LDL-C/HDL-C, ApoB/ApoA).
- Analysis: Welch’s t-test/Mann–Whitney U/chi-square for baseline comparisons; multivariable logistic regression with staged adjustment for confounders (age, sex, BMI, smoking, alcohol, hypertension, diabetes, hyperlipidemia, multivessel lesions); restricted cubic spline and ROC/AUC analyses for nonlinearity and prediction.
## Limitations
- The paper states that some patients had prior statin use, but the authors could not accurately collect duration or dosage, which may have affected lipid parameter prediction.
- The study used baseline data only, so it did not evaluate how changes in RC or lipid ratios over time affected stenosis severity.
- The authors note it was a single-center retrospective study with a relatively limited sample size.
- Evident from the text: because RC was calculated from lipid measurements and LDL-C measurement has known formula-related issues in some settings, RC estimation may still be affected by measurement precision, although the authors tried to reduce this by using direct LDL-C measurement.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
6 Valid · 0 Not valid · 1 Not checked · 61 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Thus, RC may have a stronger atherogenic effect than LDL-C.”
§ Remnant cholesterol, lipid ratios, and the severity of coronary artery lesions: a retrospective cohort study in patients with coronary heart disease > Discussion
What the sources say
- Supportedcites [16] Björnson, 2023, Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK biobank study, Eur Heart J source
The Discussion says the study’s findings are compatible with TRL/remnant particles having higher atherogenic potential than LDL. The Results also report a greater ASCVD odds ratio per 1.0 mmol/L increase in TRL/remnant cholesterol than in LDL-C. This supports the claim’s cautious wording. (LLM, conf=0.93)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“even with intensified lipid-lowering therapy, including both pharmacological treatment and lifestyle interventions to achieve target LDL-C levels and control other traditional risk factors, patients with CHD still face a higher risk of major adverse cardiovascular events (MACEs) (8, 9).”
§ Remnant cholesterol, lipid ratios, and the severity of coronary artery lesions: a retrospective cohort study in patients with coronary heart disease > Introduction
What the sources say
- Supportedcites [8] Chapman, 2011, Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management, Eur Heart J source
The Introduction and rationale (page not provided) says that treatment including lifestyle intervention and LDL-C-lowering pharmacotherapy does not normalize cardiovascular risk. It also identifies recurrent events as a concern in statin-treated CHD patients, supporting the claim of persistent risk despite treatment. (LLM, conf=0.91)
- Partly supportedcites [9] Schwartz, 2018, Alirocumab and cardiovascular outcomes after acute coronary syndrome, N Engl J Med sourceExperimental — accuracy not yet measured
The Background and Discussion report substantial recurrent cardiovascular risk in patients with a recent acute coronary syndrome despite high-intensity or maximally tolerated statin therapy. The cited trial does not establish the broader claim for all patients with CHD, or specifically for patients who achieved target LDL-C levels through medication and lifestyle interventions while controlling other risk factors. Page numbers were not supplied in our copy. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“compared with the consistent low RC group, results showed that the consistent high RC group had the greatest risk (OR: 4.32, 95% CI: 2.15–8.66, P < 0.001)”
§ Remnant cholesterol, lipid ratios, and the severity of coronary artery lesions: a retrospective cohort study in patients with coronary heart disease > Results > Inconsistency between RC and non-HDL-C and moderate to severe coronary artery stenosis
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When grouped by curve-fitting inflection points, the group with inconsistent high RC/low non-HDL-C, rather than the low RC/high non-HDL-C group, was associated with an increased risk of moderate to severe coronary stenosis compared with the consistent low RC group (OR: 2.72, P < 0.001).”
§ Remnant cholesterol, lipid ratios, and the severity of coronary artery lesions: a retrospective cohort study in patients with coronary heart disease > Abstract > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When using the third quartiles of RC and non-HDL-C for the inconsistency analysis, similar results were observed in the high RC/low non-HDL-C group without adjusting for covariates or in Model 1.”
§ Remnant cholesterol, lipid ratios, and the severity of coronary artery lesions: a retrospective cohort study in patients with coronary heart disease > Results > Inconsistency between RC and non-HDL-C and moderate to severe coronary artery stenosis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
33 more claims
Create a free account to see all 68 claims and every source verdict.
- It may state two separate claims as one. 24
- Probably not a substantial claim. 10
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Remnant cholesterol, lipid ratios, and the severity of coronary artery lesions: a retrospective cohort study in patients with coronary heart disease > Materials and methods > Lipid measurements
“Calculate lipid ratios reflecting lipid metabolism, including TG/HDL-C, TC/HDL-C, LDL-C/HDL-C, ApoA/ApoB.”
§ Remnant cholesterol, lipid ratios, and the severity of coronary artery lesions: a retrospective cohort study in patients with coronary heart disease > Results > Rc, lipid ratios and moderate to severe coronary artery stenosis
“The strongest predictors were RC [odds ratio [OR] 5.44, 95% confidence interval [CI]: 2.65–11.15, P < 0.001], ApoB/ApoA (OR: 5.00, 95% CI: 2.17–11.51, P < 0.001), and TC/HDL-C (OR: 1.49, 95% CI: 1.24–1.79, P < 0.001) (Table 2).”
Citations
Cites
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., Edelberg, J. M., Goodman, S. G., Hanotin, C., Harrington, R. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801174 · Cited by 3,634
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433 · cited 1×
“…treatment guideline of the American Diabetes Association, the diagnostic criteria for diabetes are fasting blood glucose ≥ 7.0 mmol/L, glycated hemoglobin ≥ 6.5%, or 2-h blood glucose during oral glucose tolerance test or random blood glucose ≥ 11.1 mmol/L, any of which can diagnose diabetes (22).”
InfluentialA more meaningful scoring system for determining the severity of coronary heart disease
Gensini, G. G. (1983) · The American Journal of Cardiology · doi:10.1016/s0002-9149(83)80105-2 · Cited by 2,168 · cited 1×
“…segment, by 1; the proximal left circum fl ex artery by 2.5; the mid and distal segments of the circum fl ex artery, fi rst diagonal branch, obtuse marginal branch, right coronary artery, and posterior descending artery by 1; the second diagonal branch and posterior lateral branch by 0.5, etc.) (24).”
InfluentialVirani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598
Silverman, M. G., Ference, B. A., Im, K., Wiviott, S. D., Giugliano, R. P., Grundy, S. M., Braunwald, E., & Sabatine, M. S. (2016) · JAMA · doi:10.1001/jama.2016.13985 · Cited by 1,483
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227
Interplay between inflammation and thrombosis in cardiovascular pathology
Stark, K., & Massberg, S. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00552-1 · Cited by 1,033
Varbo, A., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2013) · Circulation · doi:10.1161/circulationaha.113.003008 · Cited by 692
Navarese, E. P., Robinson, J. G., Kowalewski, M., Kolodziejczak, M., Andreotti, F., Bliden, K., Tantry, U., Kubica, J., Raggi, P., & Gurbel, P. A. (2018) · JAMA · doi:10.1001/jama.2018.2525 · Cited by 549
Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease
Castañer, O., Pintó, X., Subirana, I., Amor, A. J., Ros, E., Hernáez, Á., Martínez-González, M. Á., Corella, D., Salas-Salvadó, J., Estruch, R., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.10.008 · Cited by 540
Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: A primary prevention study
Quispe, R., Martin, S. S., Michos, E. D., Lamba, I., Blumenthal, R. S., Saeed, A., Lima, J., Puri, R., Nomura, S., Tsai, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab432 · Cited by 441
Che, B., Zhong, C., Zhang, R., Pu, L., Zhao, T., Zhang, Y., & Han, L. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01762-2 · Cited by 382
Wadström, B. N., Wulff, A. B., Pedersen, K. M., Jensen, G. B., & Nordestgaard, B. G. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab705 · Cited by 234
Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction
Stähli, B. E., Varbella, F., Linke, A., Schwarz, B., Felix, S. B., Seiffert, M., Kesterke, R., Nordbeck, P., Witzenbichler, B., Lang, I. M., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307823 · Cited by 188 · cited 1×
““ Multivessel lesions ” was de fi ned as at least two vessels with a diameter of 2.25 – 5.75 mm had ≥ 70% stenosis, and the culprit lesion could be clearly identi fi ed (25).”
InfluentialCui, C., Liu, L., Qi, Y., Han, N., Xu, H., Wang, Z., Shang, X., Han, T., Zha, Y., Wei, X., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02244-9 · Cited by 186 · cited 1×
“Insulin resistance plays a crucial role in the development of AS (37, 38).”
Self-citationBjörnson, E., Adiels, M., Taskinen, M.-R., Burgess, S., Rawshani, A., Borén, J., & Packard, C. J. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad337 · Cited by 183
Wilson, P. W. F., Jacobson, T. A., Martin, S. S., Jackson, E. J., Le, N.-A., Davidson, M. H., Vesper, H. W., Frikke-Schmidt, R., Ballantyne, C. M., & Remaley, A. T. (2021) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2021.09.046 · Cited by 134
Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction
Doi, T., Langsted, A., & Nordestgaard, B. G. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.03.384 · Cited by 129
Fasting versus nonfasting and low-density lipoprotein cholesterol accuracy
Sathiyakumar, V., Park, J., Golozar, A., Lazo, M., Quispe, R., Guallar, E., Blumenthal, R. S., Jones, S. R., & Martin, S. S. (2018) · Circulation · doi:10.1161/circulationaha.117.030677 · Cited by 122
Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease
Duran, E. K., & Pradhan, A. D. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvaa296 · Cited by 109 · cited 1×
“Dyslipidemia is a well-established pathophysiological link between atherosclerosis and vascular stenosis (2).”
Navarese, E. P., Vine, D., Proctor, S., Grzelakowska, K., Berti, S., Kubica, J., & Raggi, P. (2023) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.123.319297 · Cited by 107
Elshazly, M. B., Mani, P., Nissen, S., Brennan, D. M., Clark, D., Martin, S., Jones, S. R., Quispe, R., Donnellan, E., Nicholls, S. J., et al. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487319887578 · Cited by 103
Qian, S., You, S., Sun, Y., Wu, Q., Wang, X., Tang, W., Dong, X., Liu, C.-F., Xu, T., Cao, Y., et al. (2021) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.120.010953 · Cited by 88
Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and Mortality in China
Chen, L., Chen, S., Bai, X., Su, M., He, L., Li, G., He, G., Yang, Y., Zhang, X., Cui, J., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.22558 · Cited by 83 · cited 1×
“Studies have shown that dyslipidemia, particularly elevated low-density lipoprotein cholesterol (LDL-C), is an independent risk factor for CHD (3 – 5).”
Self-citationHigh Remnant Cholesterol Level Potentiates the Development of Hypertension
Chen, M.-M., Huang, X., Xu, C., Song, X.-H., Liu, Y.-M., Yao, D., Lu, H., Wang, G., Zhang, G.-L., Chen, Z., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.830347 · Cited by 78 · cited 1×
“These biomarkers play a role in the occurrence, progression, and prognosis of CVDs. Studies have shown that high levels of RC are closely related to CVDs such as ischemic heart disease (IHD) (10, 11), peripheral arterial disease (PAD) (12, 13), and hypertension (14, 15).”
Samuel, C., Park, J., Sajja, A., Michos, E. D., Blumenthal, R. S., Jones, S. R., & Martin, S. S. (2023) · Global Heart · doi:10.5334/gh.1214 · Cited by 56
Shao, Q., Yang, Z., Wang, Y., Li, Q., Han, K., Liang, J., Shen, H., Liu, X., Zhou, Y., Ma, X., et al. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.63397 · Cited by 49
Self-citationHao, Q.-Y., Gao, J.-W., Yuan, Z.-M., Gao, M., Wang, J.-F., Schiele, F., Zhang, S.-L., & Liu, P.-M. (2022) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.122.014116 · Cited by 49 · cited 1×
“In a prospective study involving 6,544 individuals without atherosclerotic cardiovascular disease (ASCVD), RC levels were closely associated with the severity of coronary artery calci fi cation, a relationship that remained signi fi cant even in patients with well-controlled LDL-C levels (28).”
Zhou, D., Liu, X., Lo, K. K.-H., Huang, Y., & Feng, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1012383 · Cited by 39 · cited 1×
“However, in terms of cardiovascular mortality, individuals with a TC/HDL-C ratio >4.22 showed a signi fi cantly increased risk of cardiovascular death (36).”
InfluentialHan, M., Huang, K., Shen, C., Hu, H., Liu, F., Li, J., Yang, X., Chen, J.-C., Liu, X., Cao, J., et al. (2024) · Stroke · doi:10.1161/strokeaha.124.046811 · Cited by 38 · cited 1×
“A prospective cohort study based on the China-PAR project found that elevated inconsistency in RC, rather than elevated LDL-C, was an independent factor for increasing the risk of stroke and IS, but was not related to the risk of hemorrhagic stroke (40).”
Self-citationAssociation of LDL-C/HDL-C ratio with coronary heart disease: A meta-analysis
Hu, S., Fan, H., Zhang, S., Chen, C., You, Y., Wang, C., Li, J., Luo, L., Cheng, Y., Zhou, M., et al. (2024) · Indian Heart Journal · doi:10.1016/j.ihj.2024.01.014 · Cited by 33 · cited 1×
“A meta-analysis of 12 high-qualityclinicalstudies founda positive correlationbetweenLDL-C/HDL-Cratio(LHR)andCHD,suggesting that LHR may serve as a potential indicator for assessing CHD risk (35).”
Self-citationO’Hagan, R., González‐Cantero, Á., Patel, N. H., et al. (2022) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2022.08.027 · Cited by 29
Li, T., Yuan, D., Wang, P., Jia, S., Zhang, C., Zhu, P., Song, Y., Tang, X., Zhao, X., Gao, Z., et al. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01733-8 · Cited by 23
Wang, J., Jin, R., Jin, X., Wu, Z., Zhang, H., Han, Z., Xu, Z., Liu, Y., Zhao, X., Guo, X., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029352 · Cited by 21
Impact of Remnant Lipoprotein on Coronary Plaque Components
Matsuo, N., Matsuoka, T., Onishi, S., Yamamoto, H., Kato, A., Makino, Y., & Kihara, S. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.26328 · Cited by 18 · cited 1×
“These plaques had a higher risk of rupture and signi fi cantly increased risk of recurrent cardiovascular events in patients with CHD (27).”
Residual lipidic risk beyond low-density lipoprotein cholesterol: new challenges and opportunities
Crea, F. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad671 · Cited by 14
Methods of Calculating Low-Density Lipoprotein Cholesterol Level
Brown, W. V. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0042 · Cited by 13
Yang, R., Zhang, J., Yu, X., Yang, G., & Cai, J. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae001 · Cited by 12
A potentially underestimated predictor of coronary artery disease risk: The ApoB/ApoA1 ratio
Li, B., Zhao, X., Ding, Y., & Zhang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32084 · Cited by 11 · cited 1×
“…a Mendelian randomization (MR) study utilizing summary data from a genome-wide association study (GWAS) of the ApoB/ ApoA1 ratio (BAR), Lp(a), and TG in a European population con fi rmed a causal relationship between BAR and CHD, emphasizing that BAR was an independent risk factor for CHD (34).”
Acute Coronary Syndrome in Patients With Inflammatory Bowel Diseases: The Plaque and the Thrombus
Theocharidou, E., Gossios, T. D., & Karagiannis, A. I. (2017) · Angiology · doi:10.1177/0003319717695701 · Cited by 4
Research works printed but not linked: 2
- Xuyang, 2022, Effects of cholesterol in triglyceride-rich lipoproteins on cardiovascular disease and all-cause mortality, Chin Circ J, 37, 920, 10.3969/j.issn.1000-3614.2022.09.009 · doi:10.3969/j.issn.1000-3614.2022.09.009
- 2024, Chinese hypertension prevention and treatment guideline (revised edition 2024), Chin J Hypertens (Chin Engl), 32, 603, 10.16439/j.issn.1673-7245.2024.07.002 · doi:10.16439/j.issn.1673-7245.2024.07.002
Cited by
Zhang, P., Mo, D.-G., Dong, C., Zeng, W., Li, N., Wu, J., Wang, G., & Dai, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1701364 · Cited by 5
Association Between the Remnant Cholesterol Inflammation Index and Cardiac Syndrome X
Aktaş, İ., Yaşar, E., & Uçkaç, K. (2026) · Diagnostics · doi:10.3390/diagnostics16081113 · Cited by 2
“In various cohorts, it has been demonstrated that individuals with high remnant cholesterol levels have a significantly higher incidence of myocardial infarction, atherosclerotic events, and coronary lesion severity [36,37].”
Lv, L., Guo, Y. H., Ren, Y., Li, B., Li, X., Han, Q., & Wang, H. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1803996 · Cited by 1
“Dyslipidemia is a pivotal driver of atherosclerosis and is closely associated with the severity of coronary artery stenosis (8, 9).”
Mansoursamaei, A., Yadegar, A., Mohammadi, F., Seyedi, S. A., Rabizadeh, S., Reyhan, S. K., Esteghamati, A., & Nakhjavani, M. (2026) · Health Science Reports · doi:10.1002/hsr2.72875 · Cited by 1
“Although most evidence remains observational, lipid ratios may help identify residual metabolic and cardiovascular risk not fully captured by standard lipid parameters [101, 133].”
Remnant cholesterol and lipid ratios predict the relapse of neuromyelitis optica spectrum disorder
Wang, Z., Huang, T., Cui, B., Cheng, J., Pang, X., Zhang, M., Guo, J., & Meng, H. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-025-02846-6 · Cited by 1
“RC has increasingly been recognised as a potential factor in the pathogen‑ esis of cardiovascular diseases, metabolic disorders, and some autoimmune diseases [13, 32, 34, 35].”
Self-citation
Metadata
- Authors
- Li, Y., Zhai, Y., Hu, S., Liu, J., Zhang, W., Yue, J., & Wang, Z.
- Affiliations
- Inner Mongolia University of Science and Technology (CN)
- Corresponding author
- Yue, Jianwei
- Wang, Zichao
- Venue
- Frontiers in Cardiovascular Medicine
- Publisher
- Frontiers Media SA
- Published
- 2025-03-10
- Volume
- 12
- Pages
- 1516326-1516326
- ISSN
- 2297-055X (ISSN-L)
- PMC
- PMC11930836
- OpenAlex
- W4408272998
- Semantic Scholar
- 95d7d70625694643fbfe7be658b5ef7978104550
- Cited by
- 7
- References
- 44
- Citations by year
- 2026: 6 · 2025: 1
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Cardiovascular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- remnant cholesterol, lipid ratios, coronary stenosis severity, coronary artery disease, Gensini score, non-HDL cholesterol, triglyceride to HDL cholesterol ratio, residual cardiovascular risk, atherosclerotic plaque, biomarkers, risk prediction, HDL cholesterol, triglycerides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.